Scoparone Induces Expression of Pluripotency Transcription Factors SOX2 and NANOG in Dermal Papilla Cells

Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved..

BACKGROUND/AIM: Dermal papilla cells (DPCs) regulate hair follicle development. We aimed to investigate the effect of scoparone from Dendrobium densiflorum on DPCs in the induction of stem cell properties and pluripotency-related proteins.

MATERIALS AND METHODS: DPC viability was evaluated by the MTT assay. Apoptosis or necrosis of DPCs was determined by Hoecsht33342/PI nuclear staining analysis. Expression of OCT4, NANOG and SOX2 genes was determined using Real-Time Polymerase Chain Reaction (PCR). Immunocytochemistry and western blot analysis were performed to determine pluripotency related proteins.

RESULTS: Scoparone increased the expression of pluripotency related transcription factors SOX2 and NANOG, while it had minimal effects on OCT4 levels. Scoparone exerted its stemness-enhancing activity through the up-regulation of Akt-dependent inhibition of GSK3β, resulting in increased cellular levels of β-catenin.

CONCLUSION: Our results show a potential novel activity and mechanism of action of scoparone on human DPCs that could facilitate the development of hair enrichment approaches.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:35

Enthalten in:

In vivo (Athens, Greece) - 35(2021), 5 vom: 19. Sept., Seite 2589-2597

Sprache:

Englisch

Beteiligte Personen:

Suwanprakorn, Nattha [VerfasserIn]
Chanvorachote, Pithi [VerfasserIn]
Tongyen, Thitiporn [VerfasserIn]
Sritularak, Boonchoo [VerfasserIn]
Suvanprakorn, Pichit [VerfasserIn]

Links:

Volltext

Themen:

Coumarins
Dermal papilla
H5841PDT4Y
Journal Article
NANOG
NANOG protein, human
Nanog Homeobox Protein
Pluripotency
SOX2
SOX2 protein, human
SOXB1 Transcription Factors
Scoparone
Stemness

Anmerkungen:

Date Completed 23.08.2021

Date Revised 15.09.2021

published: Print

Citation Status MEDLINE

doi:

10.21873/invivo.12541

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM329544098